1、2025/5/6 18:04sec.gov/Archives/edgar/data/2030617/000182912625002912/picardmedical_s1a.htmhttps:/www.sec.gov/Archives/edgar/data/2030617/000182912625002912/picardmedical_s1a.htm1/187S-1/A 1 picardmedical_s1a.htm S-1/A As filed with the U.S.Securities and Exchange Commission on April 24,2025.Registra

2、tion No.333-286295 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 AMENDMENT No.1toFORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Picard Medical,Inc.(Exact name of registrant as specified in its charter)Delaware 3841 86-3212894(State or other jurisdiction ofinco

3、rporation or organization)(Primary Standard IndustrialClassification Number)(I.R.S.EmployerIdentification No.)1992 E SilverlakeTucson AZ,85713(520)545-1234(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Patrick NJ SchnegelsbergChief Exe

4、cutive OfficerPicard Medical,Inc.1992 E SilverlakeTucson AZ,85713(520)545-1234(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Michael J.BlankenshipBeniamin D.SmolijWinston&Strawn LLP800 Capitol St.,Suite 2400,Houston,TX 77002-2925(713)651-2600

5、 Richard A.Friedman,Esq.Sean F.Reid,Esq.Emily Mastoloni Esq.Sheppard,Mullin,Richter&Hampton LLP30 Rockefeller PlazaNew York,NY 10112-0015(212)653-8700 Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this Registration Statement.If any

6、 of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,ple